NCT00433407View on ClinicalTrials.gov

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

February 28, 2006

Conditions
Breast CancerLung CancerOvarian CancerProstate CancerSarcomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

trastuzumab

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00433407 - T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | Biotech Hunter | Biotech Hunter